Federal Register / Vol. 81, No. 30 / Tuesday, February 16, 2016 / Notices 7819 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Commission on Childhood 

Vaccines; Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Public Law 92–463), notice is hereby 

given of the following meeting: 

Name: Advisory Commission on 

Childhood Vaccines (ACCV). 

Date and Time: March 3, 2016, 10:00 

a.m. to 3:15 p.m. EDT. 

Place: Audio Conference Call and 

Adobe Connect Pro. 

The ACCV will meet on Thursday, 

March 3, 2016, from 10:00 a.m. to 3:15 

p.m. (EDT). The public can join the 

meeting by: 

1. (Audio Portion) Calling the 

conference phone number 1–800–779– 

3561 and providing the following 

information: 

Leaders Name: Dr. Narayan Nair. 

Password: 8164763. 

2. (Visual Portion) Connecting to the 

ACCV Adobe Connect Pro Meeting 

using the following URL: https://

hrsa.connectsolutions.com/accv/ (copy 

and paste the link into your browser if 

it does not work directly and enter as a 

guest). Participants should call and 

connect 15 minutes prior to the meeting 

in order for logistics to be set up. If you 

have never attended an Adobe Connect 

meeting, please test your connection 

using the following URL: https://

hrsa.connectsolutions.com/common/

help/en/support/meeting_test.htm and 

get a quick overview by following URL: 

http://www.adobe.com/go/connectpro_

overview. Call (301) 443–6634 or send 

an email to aherzog@hrsa.gov if you are 

having trouble connecting to the 

meeting site. 

Agenda: The agenda items for the 

March 2016 meeting will include, but 

are not limited to, updates from the 

Division of Injury Compensation 

Programs (DICP), Department of Justice 

(DOJ), National Vaccine Program Office 

(NVPO), Immunization Safety Office 

(Centers for Disease Control and 

Prevention), National Institute of 

Allergy and Infectious Diseases 

(National Institutes of Health) and 

Center for Biologics, Evaluation and 

Research (Food and Drug 

Administration). A draft agenda and 

additional meeting materials will be 

posted on the ACCV Web site (http://

www.hrsa.gov/vaccinecompensation/

accv.htm) prior to the meeting. Agenda 

items are subject to change as priorities 

dictate. 

Public Comment: Persons interested 

in providing an oral presentation should 

submit a written request, along with a 

copy of their presentation to: Annie 

Herzog, DICP, Healthcare Systems 

Bureau (HSB), Health Resources and 

Services Administration (HRSA), Room 

8N146B, 5600 Fishers Lane, Rockville, 

Maryland 20857 or email: aherzog@

hrsa.gov. Requests should contain the 

name, address, telephone number, email 

address, and any business or 

professional affiliation of the person 

desiring to make an oral presentation. 

Groups having similar interests are 

requested to combine their comments 

and present them through a single 

representative. The allocation of time 

may be adjusted to accommodate the 

level of expressed interest. DICP will 

notify each presenter by email, mail, or 

telephone of their assigned presentation 

time. Persons who do not file an 

advance request for a presentation, but 

desire to make an oral statement, may 

announce it at the time of the public 

comment period. Public participation 

and ability to comment will be limited 

to space and time as it permits. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the contact person listed below at 

least 10 days prior to the meeting. 

FOR FURTHER INFORMATION CONTACT: 

Anyone requiring information regarding 

the ACCV should contact Annie Herzog, 

DICP, HSB, HRSA, Room 8N146B, 5600 

Fishers Lane, Rockville, Maryland 

20857; telephone (301) 443–6593, or 

email: aherzog@hrsa.gov. 

Jackie Painter, 

Director, Division of the Executive Secretariat. 

[FR Doc. 2016–03015 Filed 2–12–16; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Biological Chemistry and 

Macromolecular Biophysics. 

Date: March 1, 2016. 

Time: 3:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: David R Jollie, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4150, 

MSC 7806, Bethesda, MD 20892, (301)–435– 

1722, jollieda@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Investigations on Primary Immunodeficiency 

Diseases. 

Date: March 3, 2016. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Jin Huang, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4095G, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1230, jh377p@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR 

Review: Synthetic Psychoactive Drugs and 

Strategic Approaches to Counteract Their 

Deleterious Effects. 

Date: March 4, 2016. 

Time: 11:00 a.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Nicholas Gaiano, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5178, 

MSC 7844, Bethesda, MD 20892–7844, 301– 

435–1033, gaianonr@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 9, 2016. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2016–02972 Filed 2–12–16; 8:45 am] 

BILLING CODE 4140–01–P 

mstockstill on DSK4VPTVN1PROD with NOTICES